Oncology Institute (TOI) Competitors $0.14 +0.00 (+2.87%) (As of 09:15 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TOI vs. MRAI, CCM, OPGN, PMD, BRTX, OTRK, ATIP, MGRX, ATPC, and KDLYShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Marpai (MRAI), Concord Medical Services (CCM), OpGen (OPGN), Psychemedics (PMD), BioRestorative Therapies (BRTX), Ontrak (OTRK), ATI Physical Therapy (ATIP), Mangoceuticals (MGRX), Agape ATP (ATPC), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry. Oncology Institute vs. Marpai Concord Medical Services OpGen Psychemedics BioRestorative Therapies Ontrak ATI Physical Therapy Mangoceuticals Agape ATP Kindly MD Marpai (NASDAQ:MRAI) and Oncology Institute (NASDAQ:TOI) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, community ranking, risk, profitability, media sentiment, analyst recommendations and institutional ownership. Does the MarketBeat Community believe in MRAI or TOI? Oncology Institute received 2 more outperform votes than Marpai when rated by MarketBeat users. CompanyUnderperformOutperformMarpaiOutperform Votes266.67% Underperform Votes133.33% Oncology InstituteOutperform Votes466.67% Underperform Votes233.33% Which has preferable valuation and earnings, MRAI or TOI? Marpai has higher earnings, but lower revenue than Oncology Institute. Marpai is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$37.15M0.61-$28.75M-$2.64-0.62Oncology Institute$324.24M0.03-$83.07M-$0.78-0.17 Is MRAI or TOI more profitable? Oncology Institute has a net margin of -17.63% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% Oncology Institute -17.63%-186.83%-34.58% Does the media favor MRAI or TOI? In the previous week, Marpai and Marpai both had 3 articles in the media. Marpai's average media sentiment score of 0.30 beat Oncology Institute's score of 0.21 indicating that Marpai is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Marpai 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Oncology Institute 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate MRAI or TOI? Marpai currently has a consensus target price of $6.00, suggesting a potential upside of 265.85%. Oncology Institute has a consensus target price of $2.50, suggesting a potential upside of 1,738.24%. Given Oncology Institute's higher probable upside, analysts plainly believe Oncology Institute is more favorable than Marpai.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marpai 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, MRAI or TOI? Marpai has a beta of 4.69, suggesting that its stock price is 369% more volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Do institutionals & insiders hold more shares of MRAI or TOI? 49.8% of Marpai shares are held by institutional investors. Comparatively, 36.9% of Oncology Institute shares are held by institutional investors. 61.3% of Marpai shares are held by insiders. Comparatively, 9.5% of Oncology Institute shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryMarpai and Oncology Institute tied by winning 7 of the 14 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.27M$952.61M$5.07B$8.90BDividend YieldN/AN/A4.99%4.07%P/E Ratio-0.175.5187.8613.46Price / Sales0.031.371,228.8287.66Price / CashN/A43.0439.5136.27Price / Book0.652.966.946.30Net Income-$83.07M-$52.07M$119.12M$225.93M7 Day Performance-42.18%-9.44%-1.84%-1.32%1 Month Performance-62.21%-11.03%-3.65%0.60%1 Year Performance-93.87%-13.01%31.64%26.23% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute2.3174 of 5 stars$0.14+2.9%$2.50+1,738.2%-94.1%$10.27M$324.24M-0.17660Gap DownMRAIMarpai2.0113 of 5 stars$1.64+13.1%$6.00+265.9%+80.2%$22.53M$37.15M-0.62150CCMConcord Medical Services0.3453 of 5 stars$4.35-3.3%N/A-58.6%$18.88M$75.69M0.00970Gap UpOPGNOpGenN/A$1.99+1.5%N/A-55.8%$16.64M$3.42M0.00100News CoveragePMDPsychemedics0.5329 of 5 stars$2.33-0.4%N/A+11.0%$13.72M$22.10M-4.57140BRTXBioRestorative Therapies3.7191 of 5 stars$1.49+6.4%$18.00+1,108.1%-22.2%$10.31M$150,000.00-0.927Analyst RevisionNews CoverageGap UpOTRKOntrak2.7304 of 5 stars$1.72-6.0%$45.00+2,516.3%-79.4%$7.26M$12.74M0.00250Gap DownATIPATI Physical Therapy0.224 of 5 stars$1.59-7.6%N/A-78.2%$7.01M$699.02M0.005,600MGRXMangoceuticals0.508 of 5 stars$2.49+0.8%N/A-98.1%$6.20M$730,000.000.003ATPCAgape ATP0.013 of 5 stars$1.44+2.9%N/A-92.4%$5.75M$1.43M0.0040KDLYKindly MD0.1582 of 5 stars$0.93+2.2%N/AN/A$5.56MN/A0.00N/AGap Up Related Companies and Tools Related Companies Marpai Alternatives Concord Medical Services Alternatives OpGen Alternatives Psychemedics Alternatives BioRestorative Therapies Alternatives Ontrak Alternatives ATI Physical Therapy Alternatives Mangoceuticals Alternatives Agape ATP Alternatives Kindly MD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TOI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
